Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Cancelas, J; Villanueva-Penacarrillo, ML; Valverde, I; Malaisse, WJ
   Suppression by exendin(9-39)amide of glucagon-like peptide-1 insulinotropic action in rats infused with dimethyl ester of succinic acid
   ENDOCRINE
   
   J. Cancelas et al., "Suppression by exendin(9-39)amide of glucagon-like peptide-1 insulinotropic action in rats infused with dimethyl ester of succinic acid", ENDOCRINE, 15(3), 2001, pp. 283-285
2. Cancelas, J; Villanueva-Penacarrillo, ML; Valvede, I; Malaisse, WJ
   Potentiation by glutamic acid dimethyl ester of GLP-1 insulinotropic action in fed anaesthetized rats
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   J. Cancelas et al., "Potentiation by glutamic acid dimethyl ester of GLP-1 insulinotropic action in fed anaesthetized rats", INT J MOL M, 8(5), 2001, pp. 531-532
3. Cancelas, J; Villanueva-Penacarrillo, ML; Valverde, I; Malaisse, WJ
   Synergistic insulinotropic effects of succinic acid dimethyl ester and exendin-4 in anaesthetized rats
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   J. Cancelas et al., "Synergistic insulinotropic effects of succinic acid dimethyl ester and exendin-4 in anaesthetized rats", INT J MOL M, 8(3), 2001, pp. 269-271
4. Valverde, I; Cancelas, J; Villanueva-Penacarrillo, ML; Malaisse, WJ
   Potentiation by methyl pyruvate of GLP-1 insulinotropic action in normal rats
   INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
   
   I. Valverde et al., "Potentiation by methyl pyruvate of GLP-1 insulinotropic action in normal rats", INT J MOL M, 7(6), 2001, pp. 621-623
5. Sivarajah, P; Wheeler, MB; Irwin, DM
   Evolution of receptors for proglucagon-derived peptides: isolation of frogglucagon receptors
   COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY B-BIOCHEMISTRY & MOLECULAR BIOLOGY
   
   P. Sivarajah et al., "Evolution of receptors for proglucagon-derived peptides: isolation of frogglucagon receptors", COMP BIOC B, 128(3), 2001, pp. 517-527
6. Meneilly, GS; McIntosh, CHS; Pederson, RA; Habener, JF; Gingerich, R; Egan, JM; Elahi, D
   Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake inelderly patients with diabetes
   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES
   
   G.S. Meneilly et al., "Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake inelderly patients with diabetes", J GERONT A, 56(11), 2001, pp. M681-M685
7. Vara, E; Arias-Diaz, J; Garcia, C; Balibrea, JL; Blazquez, E
   Glucagon-like peptide-1(7-34) amide stimulates surfactant secretion in human type II pneumocytes
   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
   
   E. Vara et al., "Glucagon-like peptide-1(7-34) amide stimulates surfactant secretion in human type II pneumocytes", AM J R CRIT, 163(4), 2001, pp. 840-846
8. Ronnblom, A; Hellstrom, PM; Holst, JJ; Theodorsson, E; Danielsson, A
   Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy
   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
   
   A. Ronnblom et al., "Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy", EUR J GASTR, 13(7), 2001, pp. 825-831
9. Gutniak, MK; Svartberg, J; Hellstrom, PM; Holst, JJ; Adner, N; Ahren, B
   Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes
   JOURNAL OF INTERNAL MEDICINE
   
   M.K. Gutniak et al., "Antidiabetogenic action of glucagon-like peptide-1 related to administration relative to meal intake in subjects with type 2 diabetes", J INTERN M, 250(1), 2001, pp. 81-87
10. Creutzfeldt, W
    The entero-insular axis in type 2 diabetes - incretins as therapeutic agents
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    W. Creutzfeldt, "The entero-insular axis in type 2 diabetes - incretins as therapeutic agents", EXP CL E D, 109, 2001, pp. S288-S303
11. Ling, Z; Wu, D; Zambre, Y; Flamez, D; Drucker, DJ; Pipeleers, DG; Schuit, FC
    Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice
    VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
    
    Z. Ling et al., "Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice", VIRCHOWS AR, 438(4), 2001, pp. 382-387
12. Guenifi, A; Ahren, B; Abdel-Halim, SM
    Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro
    PANCREAS
    
    A. Guenifi et al., "Differential effects of glucagon-like peptide-1 (7-36)amide versus cholecystokinin on arginine-induced islet hormone release in vivo and in vitro", PANCREAS, 22(1), 2001, pp. 58-64
13. Chang, XQ; Keller, D; Bjorn, S; Led, JJ
    Structure and folding of glucagon-like peptide-1-(7-36)-amide in aqueous trifluoroethanol studied by NMR spectroscopy
    MAGNETIC RESONANCE IN CHEMISTRY
    
    X.Q. Chang et al., "Structure and folding of glucagon-like peptide-1-(7-36)-amide in aqueous trifluoroethanol studied by NMR spectroscopy", MAGN RES CH, 39(8), 2001, pp. 477-483
14. Verdich, C; Toubro, S; Buemann, B; Madsen, JL; Holst, JJ; Astrup, A
    The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction
    INTERNATIONAL JOURNAL OF OBESITY
    
    C. Verdich et al., "The role of postprandial releases of insulin and incretin hormones in meal-induced satiety - effect of obesity and weight reduction", INT J OBES, 25(8), 2001, pp. 1206-1214
15. Flint, A; Raben, A; Ersboll, AK; Holst, JJ; Astrup, A
    The effect of physiological levels of glucagon-like peptide-1 on appetite,gastric emptying, energy and substrate metabolism in obesity
    INTERNATIONAL JOURNAL OF OBESITY
    
    A. Flint et al., "The effect of physiological levels of glucagon-like peptide-1 on appetite,gastric emptying, energy and substrate metabolism in obesity", INT J OBES, 25(6), 2001, pp. 781-792
16. Hayashi, T; Kageyama, Y; Ishizaka, K; Xia, GB; Kihara, K; Oshima, H
    Requirement of Notch 1 and its ligand Jagged 2 expressions for spermatogenesis in rat and human testes
    JOURNAL OF ANDROLOGY
    
    T. Hayashi et al., "Requirement of Notch 1 and its ligand Jagged 2 expressions for spermatogenesis in rat and human testes", J ANDROLOGY, 22(6), 2001, pp. 999-1011
17. Pacini, G; Thomaseth, K; Ahren, B
    Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    G. Pacini et al., "Contribution to glucose tolerance of insulin-independent vs. insulin-dependent mechanisms in mice", AM J P-ENDO, 281(4), 2001, pp. E693-E703
18. Brandt, A; Katschinski, M; Arnold, R; Polonsky, KS; Goke, B; Byrne, MM
    GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    A. Brandt et al., "GLP-1-induced alterations in the glucose-stimulated insulin secretory dose-response curve", AM J P-ENDO, 281(2), 2001, pp. E242-E247
19. Edwards, CMB; Stanley, SA; Davis, R; Brynes, AE; Frost, GS; Seal, LJ; Ghatei, MA; Bloom, SR
    Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    C.M.B. Edwards et al., "Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers", AM J P-ENDO, 281(1), 2001, pp. E155-E161
20. Hallbrink, M; Holmqvist, T; Olsson, M; Ostenson, CG; Efendic, S; Langel, U
    Different domains in the third intracellular loop of the GLP-1 receptor are responsible for G alpha(s) and G alpha(i)/G alpha(o) activation
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY
    
    M. Hallbrink et al., "Different domains in the third intracellular loop of the GLP-1 receptor are responsible for G alpha(s) and G alpha(i)/G alpha(o) activation", BBA-PROT ST, 1546(1), 2001, pp. 79-86
21. Mommsen, TP; Conlon, JM; Irwin, DM
    Amphibian glucagon family peptides: potent metabolic regulators in fish hepatocytes
    REGULATORY PEPTIDES
    
    T.P. Mommsen et al., "Amphibian glucagon family peptides: potent metabolic regulators in fish hepatocytes", REGUL PEPT, 99(2-3), 2001, pp. 111-118
22. Irwin, DM
    Molecular evolution of proglucagon
    REGULATORY PEPTIDES
    
    D.M. Irwin, "Molecular evolution of proglucagon", REGUL PEPT, 98(1-2), 2001, pp. 1-12
23. O'Harte, FPM; Mooney, MH; Kelly, CMN; McKillop, AM; Flatt, PR
    Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice
    REGULATORY PEPTIDES
    
    F.P.M. O'Harte et al., "Degradation and glycemic effects of His(7)-glucitol glucagon-like peptide-1(7-36)amide in obese diabetic ob/ob mice", REGUL PEPT, 96(3), 2001, pp. 95-104
24. Pospisilik, JA; Hinke, SA; Pederson, RA; Hoffmann, T; Rosche, F; Schlenzig, D; Glund, K; Heiser, U; McIntosh, CHS; Demuth, HU
    Metabolism of glucagon by dipeptidyl peptidase IV (CD26)
    REGULATORY PEPTIDES
    
    J.A. Pospisilik et al., "Metabolism of glucagon by dipeptidyl peptidase IV (CD26)", REGUL PEPT, 96(3), 2001, pp. 133-141
25. Gebhard, B; Holst, JJ; Biegelmayer, C; Miholic, J
    Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome
    DIGESTIVE DISEASES AND SCIENCES
    
    B. Gebhard et al., "Postprandial GLP-1, norepinephrine, and reactive hypoglycemia in dumping syndrome", DIG DIS SCI, 46(9), 2001, pp. 1915-1923
26. Larsen, J; Hylleberg, B; Ng, K; Damsbo, P
    Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtainacceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment
    DIABETES CARE
    
    J. Larsen et al., "Glucagon-like peptide-1 infusion must be maintained for 24 h/day to obtainacceptable glycemia in type 2 diabetic patients who are poorly controlled on sulphonylurea treatment", DIABET CARE, 24(8), 2001, pp. 1416-1421
27. Bungo, T; Kawakami, S; Ohgushi, A; Sashihara, K; Saito, N; Sugahara, K; Hasegawa, S; Denbow, DM; Furuse, M
    Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like, peptide-1 in the neonatal chick
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    
    T. Bungo et al., "Intracerebroventricular injection of fusaric acid attenuates the anorexia by glucagon-like, peptide-1 in the neonatal chick", PHARM BIO B, 70(2-3), 2001, pp. 251-255
28. Seydoux, G; Schedl, T
    The germline in C-elegans: Origins, proliferation, and silencing
    INTERNATIONAL REVIEW OF CYTOLOGY - A SURVEY OF CELL BIOLOGY, VOL 203
    
    G. Seydoux e T. Schedl, "The germline in C-elegans: Origins, proliferation, and silencing", INT REV CYT, 203, 2001, pp. 139-185
29. Holst, JJ; Orskov, C
    Incretin hormones - an update
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    
    J.J. Holst e C. Orskov, "Incretin hormones - an update", SC J CL INV, 61, 2001, pp. 75-85
30. Hanazawa, M; Mochii, M; Ueno, N; Kohara, Y; Iino, Y
    Use of cDNA subtraction and RNA interference screens in combination reveals genes required for germ-line development in Caenorhabditis elegans
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    M. Hanazawa et al., "Use of cDNA subtraction and RNA interference screens in combination reveals genes required for germ-line development in Caenorhabditis elegans", P NAS US, 98(15), 2001, pp. 8686-8691
31. Parkes, DG; Pittner, R; Jodka, C; Smith, P; Young, A
    Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    D.G. Parkes et al., "Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro", METABOLISM, 50(5), 2001, pp. 583-589
32. Peters, CT; Choi, YH; Brubaker, PL; Anderson, GH
    A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats
    JOURNAL OF NUTRITION
    
    C.T. Peters et al., "A glucagon-like peptide-1 receptor agonist and an antagonist modify macronutrient selection by rats", J NUTR, 131(8), 2001, pp. 2164-2170
33. Verdich, C; Flint, A; Gutzwiller, JP; Naslund, E; Beglinger, C; Hellstrom, PM; Long, SJ; Morgan, LM; Holst, JJ; Astrup, A
    A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    C. Verdich et al., "A meta-analysis of the effect of glucagon-like peptide-1 (7-36) amide on ad libitum energy intake in humans", J CLIN END, 86(9), 2001, pp. 4382-4389
34. Toft-Nielsen, MB; Madsbad, S; Holst, JJ
    Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    M.B. Toft-Nielsen et al., "Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes", J CLIN END, 86(8), 2001, pp. 3853-3860
35. Bertin, E; Arner, P; Bolinder, J; Hagstrom-Toft, E
    Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo
    JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    
    E. Bertin et al., "Action of glucagon and glucagon-like peptide-1-(7-36) amide on lipolysis in human subcutaneous adipose tissue and skeletal muscle in vivo", J CLIN END, 86(3), 2001, pp. 1229-1234
36. Tibaduiza, EC; Chen, C; Beinborn, M
    A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    E.C. Tibaduiza et al., "A small molecule ligand of the glucagon-like peptide 1 receptor targets its amino-terminal hormone binding domain", J BIOL CHEM, 276(41), 2001, pp. 37787-37793
37. Lugari, R; Ugolotti, D; Dei Cas, A; Barilli, AL; Iotti, M; Marani, B; Orlandini, A; Gnudi, A; Zandomeneghi, R
    Urinary excretion of glucagon-like peptide 1 (GLP-1) 7-36 amide in human type 2 (non-insulin-dependent) diabetes mellitus
    HORMONE AND METABOLIC RESEARCH
    
    R. Lugari et al., "Urinary excretion of glucagon-like peptide 1 (GLP-1) 7-36 amide in human type 2 (non-insulin-dependent) diabetes mellitus", HORMONE MET, 33(9), 2001, pp. 568-571
38. Villanueva-Penacarrillo, ML; Marquez, L; Gonzalez, N; Diaz-Miguel, M; Valverde, I
    Effect of GLP-1 on lipid metabolism in human adipocytes
    HORMONE AND METABOLIC RESEARCH
    
    M.L. Villanueva-Penacarrillo et al., "Effect of GLP-1 on lipid metabolism in human adipocytes", HORMONE MET, 33(2), 2001, pp. 73-77
39. Ranganath, LR; Beety, JM; Wright, J; Morgan, LM
    Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects
    HORMONE AND METABOLIC RESEARCH
    
    L.R. Ranganath et al., "Nutrient regulation of post-heparin lipoprotein lipase activity in obese subjects", HORMONE MET, 33(1), 2001, pp. 57-61
40. Yeung, CM; Chow, BKC
    Identification of a proglucagon cDNA from Rana tigrina rugulosa that encodes two GLP-1s and that is alternatively spliced in a tissue-specific manner
    GENERAL AND COMPARATIVE ENDOCRINOLOGY
    
    C.M. Yeung e B.K.C. Chow, "Identification of a proglucagon cDNA from Rana tigrina rugulosa that encodes two GLP-1s and that is alternatively spliced in a tissue-specific manner", GEN C ENDOC, 124(2), 2001, pp. 144-151
41. Zhang, R; Nakanishi, T; Ohgushi, A; Ando, R; Yoshimatsu, T; Denbow, DM; Furuse, M
    Interaction of corticotropin-releasing factor and glucagon-like peptide-1 on behaviors in chicks
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    R. Zhang et al., "Interaction of corticotropin-releasing factor and glucagon-like peptide-1 on behaviors in chicks", EUR J PHARM, 430(1), 2001, pp. 73-78
42. Garcia-Flores, M; Zueco, JA; Alvarez, E; Blazquez, E
    Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development
    EUROPEAN JOURNAL OF BIOCHEMISTRY
    
    M. Garcia-Flores et al., "Expression of glucagon-like peptide-1 (GLP-1) receptor and the effect of GLP-1-(7-36) amide on insulin release by pancreatic islets during rat ontogenic development", EUR J BIOCH, 268(3), 2001, pp. 514-520
43. Drucker, DJ
    Minireview: The glucagon-like peptides
    ENDOCRINOLOGY
    
    D.J. Drucker, "Minireview: The glucagon-like peptides", ENDOCRINOL, 142(2), 2001, pp. 521-527
44. Dakin, CL; Gunn, I; Small, CJ; Edwards, CMB; Hay, DL; Smith, DM; Ghatei, MA; Bloom, SR
    Oxyntomodulin inhibits food intake in the rat
    ENDOCRINOLOGY
    
    C.L. Dakin et al., "Oxyntomodulin inhibits food intake in the rat", ENDOCRINOL, 142(10), 2001, pp. 4244-4250
45. Tourrel, C; Bailbe, D; Meile, MJ; Kergoat, M; Portha, B
    Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age
    DIABETES
    
    C. Tourrel et al., "Glucagon-like peptide-1 and exendin-4 stimulate beta-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age", DIABETES, 50(7), 2001, pp. 1562-1570
46. Ahren, B; Holst, JJ
    The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia
    DIABETES
    
    B. Ahren e J.J. Holst, "The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia", DIABETES, 50(5), 2001, pp. 1030-1038
47. Ritzel, R; Schulte, M; Porksen, N; Nauck, MS; Holst, JJ; Juhl, C; Marz, W; Schmitz, O; Schmiegel, WH; Nauck, MA
    Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance
    DIABETES
    
    R. Ritzel et al., "Glucagon-like peptide 1 increases secretory burst mass of pulsatile insulin secretion in patients with type 2 diabetes and impaired glucose tolerance", DIABETES, 50(4), 2001, pp. 776-784
48. Delattre, M; Felix, MA
    Development and evolution of a variable left-right asymmetry in nematodes:The handedness of P11/P12 migration
    DEVELOPMENTAL BIOLOGY
    
    M. Delattre e M.A. Felix, "Development and evolution of a variable left-right asymmetry in nematodes:The handedness of P11/P12 migration", DEVELOP BIO, 232(2), 2001, pp. 362-371
49. Miskowski, J; Li, YJ; Kimble, J
    The sys-1 gene and sexual dimorphism during gonadogenesis in Caenorhabditis elegans
    DEVELOPMENTAL BIOLOGY
    
    J. Miskowski et al., "The sys-1 gene and sexual dimorphism during gonadogenesis in Caenorhabditis elegans", DEVELOP BIO, 230(1), 2001, pp. 61-73
50. Xiao, Q; Giguere, J; Parisien, M; Jeng, W; St-Pierre, SA; Brubaker, PL; Wheeler, MB
    Biological activities of glucagon-like peptide-1 analogues in vitro and invivo
    BIOCHEMISTRY
    
    Q. Xiao et al., "Biological activities of glucagon-like peptide-1 analogues in vitro and invivo", BIOCHEM, 40(9), 2001, pp. 2860-2869
51. Brun, JF; Fedou, C; Mercier, J
    Postprandial reactive hypoglycemia
    DIABETES & METABOLISM
    
    J.F. Brun et al., "Postprandial reactive hypoglycemia", DIABETE MET, 26(5), 2000, pp. 337-351
52. Garcia-Martinez, JA; Cancelas, J; Villanueva-Penacarrillo, ML; Valverde, I; Malaisse, WJ
    Prolongation of the insulinotropic action of glucagon-like peptide 1 by the dimethyl ester of succinic acid in an animal model of type-2 diabetes
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
    
    J.A. Garcia-Martinez et al., "Prolongation of the insulinotropic action of glucagon-like peptide 1 by the dimethyl ester of succinic acid in an animal model of type-2 diabetes", INT J MOL M, 6(3), 2000, pp. 319-321
53. Al-Barazanji, KA; Arch, JRS; Buckingham, RE; Tadayyon, M
    Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats
    OBESITY RESEARCH
    
    K.A. Al-Barazanji et al., "Central exendin-4 infusion reduces body weight without altering plasma leptin in (fa/fa) Zucker rats", OBES RES, 8(4), 2000, pp. 317-323
54. Smardon, A; Spoerke, JM; Stacey, SC; Klein, ME; Mackin, N; Maine, EM
    EGO-1 is related to RNA-directed RNA polymerase and functions in germ-linedevelopment and RNA interference in C-elegans
    CURRENT BIOLOGY
    
    A. Smardon et al., "EGO-1 is related to RNA-directed RNA polymerase and functions in germ-linedevelopment and RNA interference in C-elegans", CURR BIOL, 10(4), 2000, pp. 169-178
55. Coppola, GM; Zhang, YL; Schuster, HF; Russell, ME; Hughes, TE
    1-aminomethylisoquinoline-4-carboxylates as novel dipeptidylpeptidase IV inhibitors
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    
    G.M. Coppola et al., "1-aminomethylisoquinoline-4-carboxylates as novel dipeptidylpeptidase IV inhibitors", BIOORG MED, 10(14), 2000, pp. 1555-1558
56. Xiao, Q; Jeng, W; Wheeler, MB
    Characterization of glucagon-like peptide-1 receptor-binding determinants
    JOURNAL OF MOLECULAR ENDOCRINOLOGY
    
    Q. Xiao et al., "Characterization of glucagon-like peptide-1 receptor-binding determinants", J MOL ENDOC, 25(3), 2000, pp. 321-335
57. Karashima, T; Sugimoto, A; Yamamoto, M
    Caenorhabditis elegans homologue of the human azoospermia factor DAZ is required for oogenesis but not for spermatogenesis
    DEVELOPMENT
    
    T. Karashima et al., "Caenorhabditis elegans homologue of the human azoospermia factor DAZ is required for oogenesis but not for spermatogenesis", DEVELOPMENT, 127(5), 2000, pp. 1069-1079
58. Hermann, GJ; Leung, B; Priess, JR
    Left-right asymmetry in C-elegans intestine organogenesis involves a LIN-12/Notch signaling pathway
    DEVELOPMENT
    
    G.J. Hermann et al., "Left-right asymmetry in C-elegans intestine organogenesis involves a LIN-12/Notch signaling pathway", DEVELOPMENT, 127(16), 2000, pp. 3429-3440
59. Goutte, C; Hepler, W; Mickey, KM; Priess, JR
    aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling
    DEVELOPMENT
    
    C. Goutte et al., "aph-2 encodes a novel extracellular protein required for GLP-1-mediated signaling", DEVELOPMENT, 127(11), 2000, pp. 2481-2492
60. Nauck, M; Hahn, S; Sauerwald, A; Schmiegel, W
    Lack of germline mutations in the preproglucagon gene region coding for glucagon-like peptide 1 in Type 2 diabetic (NIDDM) patients
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    M. Nauck et al., "Lack of germline mutations in the preproglucagon gene region coding for glucagon-like peptide 1 in Type 2 diabetic (NIDDM) patients", EXP CL E D, 108(2), 2000, pp. 72-75
61. Kuroyanagi, H; Kimura, T; Wada, K; Hisamoto, N; Matsumoto, K; Hagiwara, M
    SPK-1, a C-elegans SR protein kinase homologue, is essential for embryogenesis and required for germline development
    MECHANISMS OF DEVELOPMENT
    
    H. Kuroyanagi et al., "SPK-1, a C-elegans SR protein kinase homologue, is essential for embryogenesis and required for germline development", MECH DEVEL, 99(1-2), 2000, pp. 51-64
62. Ranganath, L; Morgan, L
    An osmotic stimulus-mediating glucagon-like peptide-1 (7-36 amide) (GLP-1)secretion in acarbose-induced sucrose malabsorption?
    NUTRITION
    
    L. Ranganath e L. Morgan, "An osmotic stimulus-mediating glucagon-like peptide-1 (7-36 amide) (GLP-1)secretion in acarbose-induced sucrose malabsorption?", NUTRITION, 16(1), 2000, pp. 64-65
63. Knudsen, SM; Tams, JW; Fahrenkrug, J
    Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC(1)R)
    JOURNAL OF MOLECULAR NEUROSCIENCE
    
    S.M. Knudsen et al., "Role of second extracellular loop in the function of human vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide receptor 1 (hVPAC(1)R)", J MOL NEURO, 14(3), 2000, pp. 137-146
64. Anini, Y; Jarrousse, C; Chariot, J; Nagain, C; Yanaihara, N; Sasaki, K; Bernad, N; Nguyen, DL; Bataille, D; Roze, C
    Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats
    PANCREAS
    
    Y. Anini et al., "Oxyntomodulin inhibits pancreatic secretion through the nervous system in rats", PANCREAS, 20(4), 2000, pp. 348-360
65. Perfetti, R; Merkel, P
    Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function
    EUROPEAN JOURNAL OF ENDOCRINOLOGY
    
    R. Perfetti e P. Merkel, "Glucagon-like peptide-1: a major regulator of pancreatic beta-cell function", EUR J ENDOC, 143(6), 2000, pp. 717-725
66. Meneilly, GS; Demuth, HU; McIntosh, CHS; Pederson, RA
    Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose
    DIABETIC MEDICINE
    
    G.S. Meneilly et al., "Effect of ageing and diabetes on glucose-dependent insulinotropic polypeptide and dipeptidyl peptidase IV responses to oral glucose", DIABET MED, 17(5), 2000, pp. 346-350
67. Cattaneo, M; Orlandi, R; Ronchini, C; Granelli, P; Malferrari, G; Menard, S; Biunno, I
    The expression of SEL1L and TAN-1 in normal and neoplastic cells
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    
    M. Cattaneo et al., "The expression of SEL1L and TAN-1 in normal and neoplastic cells", INT J B MAR, 15(1), 2000, pp. 26-32
68. Filipsson, K; Holst, JJ; Ahren, B
    PACAP contributes to insulin secretion after gastric glucose gavage in mice
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    
    K. Filipsson et al., "PACAP contributes to insulin secretion after gastric glucose gavage in mice", AM J P-REG, 279(2), 2000, pp. R424-R432
69. Rayner, CK; Park, HS; Wishart, JM; Kong, MF; Doran, SM; Horowitz, M
    Effects of intraduodenal glucose and fructose on antropyloric motility andappetite in healthy humans
    AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
    
    C.K. Rayner et al., "Effects of intraduodenal glucose and fructose on antropyloric motility andappetite in healthy humans", AM J P-REG, 278(2), 2000, pp. R360-R366
70. Flint, A; Raben, A; Rehfeld, JF; Holst, JJ; Astrup, A
    The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans
    INTERNATIONAL JOURNAL OF OBESITY
    
    A. Flint et al., "The effect of glucagon-like peptide-1 on energy expenditure and substrate metabolism in humans", INT J OBES, 24(3), 2000, pp. 288-298
71. Holz, GG; Leech, CA; Habener, JF
    Insulinotropic toxins as molecular probes for analysis of glucagon-like peptide-1 receptor-mediated signal transduction in pancreatic beta-cells
    BIOCHIMIE
    
    G.G. Holz et al., "Insulinotropic toxins as molecular probes for analysis of glucagon-like peptide-1 receptor-mediated signal transduction in pancreatic beta-cells", BIOCHIMIE, 82(9-10), 2000, pp. 915-926
72. Seeley, RJ; Blake, K; Rushing, PA; Benoit, S; Eng, J; Woods, SC; D'Alessio, D
    The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride
    JOURNAL OF NEUROSCIENCE
    
    R.J. Seeley et al., "The role of CNS glucagon-like peptide-1 (7-36) amide receptors in mediating the visceral illness effects of lithium chloride", J NEUROSC, 20(4), 2000, pp. 1616-1621
73. Galehshahi, FS; Goke, B; Lankat-Buttgereit, B
    A novel silencer element repressing expression of the GLP-1 receptor gene in fibroblasts and pancreatic A-cells, but not in pancreatic B- and D-cells
    PEPTIDES
    
    F.S. Galehshahi et al., "A novel silencer element repressing expression of the GLP-1 receptor gene in fibroblasts and pancreatic A-cells, but not in pancreatic B- and D-cells", PEPTIDES, 21(8), 2000, pp. 1169-1176
74. Herrmann-Rinke, C; McGregor, GP; Goke, B
    Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum
    PEPTIDES
    
    C. Herrmann-Rinke et al., "Calcitonin gene-related peptide potently stimulates glucagon-like peptide-1 release in the isolated perfused rat ileum", PEPTIDES, 21(3), 2000, pp. 431-437
75. Hartmann, B; Johnsen, AH; Orskov, C; Adelhorst, K; Thim, L; Holst, JJ
    Structure, measurement, and secretion of human glucagon-like peptide-2
    PEPTIDES
    
    B. Hartmann et al., "Structure, measurement, and secretion of human glucagon-like peptide-2", PEPTIDES, 21(1), 2000, pp. 73-80
76. Katschinski, M
    Nutritional implications of cephalic phase gastrointestinal responses
    APPETITE
    
    M. Katschinski, "Nutritional implications of cephalic phase gastrointestinal responses", APPETITE, 34(2), 2000, pp. 189-196
77. Ebinger, M; Jehle, DR; Fussgaenger, RD; Fehmann, HC; Jehle, PM
    Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    M. Ebinger et al., "Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes", AM J P-ENDO, 279(1), 2000, pp. E88-E94
78. Hansen, L; Hartmann, B; Bisgaard, T; Mineo, H; Jorgensen, PN; Holst, JJ
    Somatostatin restrains the secretion of glucagon-like peptide-1 and-2 fromisolated perfused porcine ileum
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
    
    L. Hansen et al., "Somatostatin restrains the secretion of glucagon-like peptide-1 and-2 fromisolated perfused porcine ileum", AM J P-ENDO, 278(6), 2000, pp. E1010-E1018
79. Conlon, JM
    Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research
    REGULATORY PEPTIDES
    
    J.M. Conlon, "Singular contributions of fish neuroendocrinology to mammalian regulatory peptide research", REGUL PEPT, 93(1-3), 2000, pp. 3-12
80. Bojanowska, E; Stempniak, B
    Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat
    REGULATORY PEPTIDES
    
    E. Bojanowska e B. Stempniak, "Effects of centrally or systemically injected glucagon-like peptide-1 (7-36) amide on release of neurohypophysial hormones and blood pressure in the rat", REGUL PEPT, 91(1-3), 2000, pp. 75-81
81. Gallwitz, B; Ropeter, T; Morys-Wortmann, C; Mentlein, R; Siegel, EG; Schmidt, WE
    GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro
    REGULATORY PEPTIDES
    
    B. Gallwitz et al., "GLP-1-analogues resistant to degradation by dipeptidyl-peptidase IV in vitro", REGUL PEPT, 86(1-3), 2000, pp. 103-111
82. Nishizawa, M; Nakabayashi, H; Kawai, K; Ito, T; Kawakami, S; Nakagawa, A; Niijima, A; Uchida, K
    The hepatic vagal reception of intraportal GLP-1 is via receptor differentfrom the pancreatic GLP-1 receptor
    JOURNAL OF THE AUTONOMIC NERVOUS SYSTEM
    
    M. Nishizawa et al., "The hepatic vagal reception of intraportal GLP-1 is via receptor differentfrom the pancreatic GLP-1 receptor", J AUTON NER, 80(1-2), 2000, pp. 14-21
83. Egel-Mitani, M; Andersen, AS; Diers, I; Hach, M; Thim, L; Hastrup, S; Vad, K
    Yield improvement of heterologous peptides expressed in yps1-disrupted Saccharomyces cerevisiae strains
    ENZYME AND MICROBIAL TECHNOLOGY
    
    M. Egel-Mitani et al., "Yield improvement of heterologous peptides expressed in yps1-disrupted Saccharomyces cerevisiae strains", ENZYME MICR, 26(9-10), 2000, pp. 671-677
84. Nakagaki, I; Sasaki, S; Hori, S; Kondo, W
    Ca2+ and electrolyte mobilization following agonist application to the pancreatic beta cell line HIT
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    
    I. Nakagaki et al., "Ca2+ and electrolyte mobilization following agonist application to the pancreatic beta cell line HIT", PFLUG ARCH, 440(6), 2000, pp. 828-834
85. Suga, S; Kanno, T; Ogawa, Y; Takeo, T; Kamimura, N; Wakui, M
    cAMP-independent decrease of ATP-sensitive K+ channel activity by GLP-1 inrat pancreatic beta-cells
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
    
    S. Suga et al., "cAMP-independent decrease of ATP-sensitive K+ channel activity by GLP-1 inrat pancreatic beta-cells", PFLUG ARCH, 440(4), 2000, pp. 566-572
86. Petcherski, AG; Kimble, J
    LAG-3 is a putative transcriptional activator in the C-elegans Notch pathway
    NATURE
    
    A.G. Petcherski e J. Kimble, "LAG-3 is a putative transcriptional activator in the C-elegans Notch pathway", NATURE, 405(6784), 2000, pp. 364-368
87. de Fonseca, FR; Navarro, M; Alvarez, E; Roncero, I; Chowen, JA; Maestre, O; Gomez, R; Munoz, RM; Eng, J; Blazquez, E
    Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    F.R. de Fonseca et al., "Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats", METABOLISM, 49(6), 2000, pp. 709-717
88. Knudsen, LB; Nielsen, PF; Huusfeldt, PO; Johansen, NL; Madsen, K; Pedersen, FZ; Thogersen, H; Wilken, M; Agerso, H
    Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration
    JOURNAL OF MEDICINAL CHEMISTRY
    
    L.B. Knudsen et al., "Potent derivatives of glucagon-like peptide-1 with pharmacokinetic properties suitable for once daily administration", J MED CHEM, 43(9), 2000, pp. 1664-1669
89. Lugari, R; Dell'Anna, C; Ugolotti, D; Dei Cas, A; Barilli, AL; Zandomeneghi, R; Marani, B; Lotti, M; Orlandini, A; Gnudi, A
    Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes
    HORMONE AND METABOLIC RESEARCH
    
    R. Lugari et al., "Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes", HORMONE MET, 32(10), 2000, pp. 424-428
90. Schirra, J; Houck, P; Wank, U; Arnold, R; Goke, B; Katschinski, M
    Effects of glucagon-like peptide-1 (7-36) amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans
    GUT
    
    J. Schirra et al., "Effects of glucagon-like peptide-1 (7-36) amide on antro-pyloro-duodenal motility in the interdigestive state and with duodenal lipid perfusion in humans", GUT, 46(5), 2000, pp. 622-631
91. Ahren, B; Holst, JJ; Martensson, H; Balkan, B
    Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    B. Ahren et al., "Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice", EUR J PHARM, 404(1-2), 2000, pp. 239-245
92. Ahren, B; Holst, JJ; Yu, SK
    1,5-anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice
    EUROPEAN JOURNAL OF PHARMACOLOGY
    
    B. Ahren et al., "1,5-anhydro-D-fructose increases glucose tolerance by increasing glucagon-like peptide-1 and insulin in mice", EUR J PHARM, 397(1), 2000, pp. 219-225
93. Fritsche, A; Stefan, N; Hardt, E; Schutzenauer, S; Haring, H; Stumvoll, M
    A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
    
    A. Fritsche et al., "A novel hyperglycaemic clamp for characterization of islet function in humans: assessment of three different secretagogues, maximal insulin response and reproducibility", EUR J CL IN, 30(5), 2000, pp. 411-418
94. Szayna, M; Doyle, ME; Betkey, JA; Holloway, HW; Spencer, RGS; Greig, NH; Egan, JM
    Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats
    ENDOCRINOLOGY
    
    M. Szayna et al., "Exendin-4 decelerates food intake, weight gain, and fat deposition in Zucker rats", ENDOCRINOL, 141(6), 2000, pp. 1936-1941
95. Satoh, F; Beak, SA; Small, CJ; Falzon, M; Ghatei, MA; Bloom, SR; Smith, DM
    Characterization of human and rat glucagon-like peptide-1 receptors in theneurointermediate lobe: Lack of coupling to either stimulation or inhibition of adenylyl cyclase
    ENDOCRINOLOGY
    
    F. Satoh et al., "Characterization of human and rat glucagon-like peptide-1 receptors in theneurointermediate lobe: Lack of coupling to either stimulation or inhibition of adenylyl cyclase", ENDOCRINOL, 141(4), 2000, pp. 1301-1309
96. Bollag, RJ; Zhong, Q; Phillips, P; Min, L; Zhong, L; Cameron, R; Mulloy, AL; Rasmussen, H; Qin, F; Ding, KH; Isales, CM
    Osteoblast-derived cells express functional glucose dependent insulinotropic peptide receptors
    ENDOCRINOLOGY
    
    R.J. Bollag et al., "Osteoblast-derived cells express functional glucose dependent insulinotropic peptide receptors", ENDOCRINOL, 141(3), 2000, pp. 1228-1235
97. Seeley, RJ; Woods, SC; D'Alessio, D
    Editorial: Targeted gene disruption in endocrine research - The case of glucagon-like peptide-1 and neuroendocrine function
    ENDOCRINOLOGY
    
    R.J. Seeley et al., "Editorial: Targeted gene disruption in endocrine research - The case of glucagon-like peptide-1 and neuroendocrine function", ENDOCRINOL, 141(2), 2000, pp. 473-475
98. MacLusky, NJ; Cook, S; Scrocchi, L; Shin, J; Kim, J; Vaccarino, F; Asa, SL; Drucker, DJ
    Neuroendocrine function and response to stress mice with complete disruption of glucagon-like peptide-1 receptor signaling
    ENDOCRINOLOGY
    
    N.J. MacLusky et al., "Neuroendocrine function and response to stress mice with complete disruption of glucagon-like peptide-1 receptor signaling", ENDOCRINOL, 141(2), 2000, pp. 752-762
99. Huypens, P; Ling, Z; Pipeleers, D; Schuit, F
    Glucagon receptors on human islet cells contribute to glucose competence of insulin release
    DIABETOLOGIA
    
    P. Huypens et al., "Glucagon receptors on human islet cells contribute to glucose competence of insulin release", DIABETOLOG, 43(8), 2000, pp. 1012-1019
100. Fritsche, A; Stefan, N; Hardt, E; Haring, H; Stumvoll, M
     Characterisation of beta-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion
     DIABETOLOGIA
     
     A. Fritsche et al., "Characterisation of beta-cell dysfunction of impaired glucose tolerance: Evidence for impairment of incretin-induced insulin secretion", DIABETOLOG, 43(7), 2000, pp. 852-858